AUM & Continued Monthly Net Inflows: Valour reported assets under management (AUM) of C$1.07B (US$750M) as of March 6, 2025, a 25% decrease driven by digital asset price declines. Net inflows for February remained strong at C$16.4M (US$11.4M), marking the fourth consecutive month of…

LOWELL, Mass., March 10, 2025 /PRNewswire/ — Versatope Therapeutics Incorporated, a biotechnology company developing vaccines and immuno-therapeutics announced today Edward Jordan and Sam Rasty have joined the company’s Board of Directors and Jim Tartaglia joined the Scientific Advisory…

Phase 2a clinical program demonstrates safety and efficacy for all endpoints in AD with and without secondary infection ANNAPOLIS, Md. and ORLANDO, Fla., March 10, 2025 /PRNewswire/ — Alphyn, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.